IDEAS home Printed from
MyIDEAS: Login to save this paper or follow this series

Increasing Public Sector Efficiency in Slovakia

  • Felix Hüfner

Given the deterioration in public finances, there is now very little scope for higher spending. Raising public sector efficiency would free up resources and yield better outcomes with the same inputs, helping to stimulate productivity and thus potential growth. Raising efficiency in tax collection (notably VAT) is urgently needed, plans to unify the collection of tax and social security contributions should be implemented swiftly and drawing on EU funds needs to become more efficient. In addition, raising the efficiency in healthcare should be a priority. This involves dealing with the high out-of-pocket payments and reforming the remuneration structure of doctors. Pharmaceutical spending is excessive and can be reduced, notably by further fostering generic substitution. Impediments to competition among health insurance funds should be reconsidered and the risk-equalisation system should be improved. This paper relates to the 2010 OECD Economic Review of the Slovak Republic ( Accroître l'efficacité du secteur public en Slovaquie Étant donné la dégradation des finances publiques, il n’est guère possible désormais d’augmenter les dépenses. En améliorant l’efficacité du secteur public, on dégagerait des ressources et on obtiendrait de meilleurs résultats avec les mêmes intrants, ce qui contribuerait à stimuler la productivité et donc la croissance potentielle. Il est urgent d’améliorer l’efficacité de la collecte des impôts et taxes (notamment de la TVA) ; des plans visant à unifier le recouvrement de l’impôt et des cotisations de sécurité sociale doivent être mis en oeuvre rapidement et les dispositifs de tirage sur les fonds de l’UE doivent devenir plus efficaces. En outre, améliorer l’efficacité des soins de santé devrait être une priorité. Cela implique de s’attaquer au problème du montant élevé des paiements directs et de réformer le mode de rémunération des généralistes. Les dépenses pharmaceutiques sont excessives et peuvent être réduites, notamment en encourageant le recours aux génériques. Il faudrait réexaminer les entraves à la concurrence entre caisses d’assurance-maladie et améliorer le système de répartition équitable des risques. Ce document se rapporte à l’Étude économique de la République slovaque de l’OCDE, 2010 (

If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL:
Our checks indicate that this address may not be valid because: 403 Forbidden ( [303 See Other]--> If this is indeed the case, please notify ()

Download Restriction: no

Paper provided by OECD Publishing in its series OECD Economics Department Working Papers with number 839.

in new window

Date of creation: 03 Feb 2011
Date of revision:
Handle: RePEc:oec:ecoaaa:839-en
Contact details of provider: Postal: 2 rue Andre Pascal, 75775 Paris Cedex 16
Phone: 33-(0)-1-45 24 82 00
Fax: 33-(0)-1-45 24 85 00
Web page:

More information through EDIRC

No references listed on IDEAS
You can help add them by filling out this form.

This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

When requesting a correction, please mention this item's handle: RePEc:oec:ecoaaa:839-en. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ()

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

If references are entirely missing, you can add them using this form.

If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.